Current methods for #imageanalysis are so good at picking up image features associated with #diseases some say #AI could match or even outperform doctors in the near future. But is this true, what is this all about anyway, and where is this all going?
https://t.co/qZkGLIkGzr
Current methods for #imageanalysis are so good at picking up image features associated with #diseases some say #AI could match or even outperform doctors in the near future. But is this true, what is this all about anyway, and where is this all going?
https://t.co/vznqdGPjnq
Our monthly #newsletter, News & Insights, helps keep you up to date with the latest in the world of #IP.
The latest included stories on #bioinformatics, #biomarkers, #machinelearning, and more! View it here: https://t.co/dHeBxfhNzo
Sign up on our blog: https://t.co/Z7r1ftdrPC
The fast evolving nature of #bioinformatics has enormous potential to improve human life, but also begs many questions in relation to (at least) #IP strategy, #dataprivacy, #regulation and #liability. Join us for a deep dive into these topics.
https://t.co/81eIWdwSOR
The fast evolving nature of #bioinformatics has enormous potential to improve human life, but also begs many questions in relation to (at least) #IP strategy, #dataprivacy, #regulation and #liability. Join us for a deep dive into these topics.
https://t.co/XeiRXDM1d6
The @EPOorg usually considers that if an #antibody having a particular function is known, then other #antibodies having the same function can be obtained as a matter of routine.
Read more about #patenting antibodies in Europe: https://t.co/J4y3LGEdyy
As #antibody development has evolved over the years, so has the approach taken by patent offices. Here we discuss some key considerations when filing a #patent to protect a new antibody, with a particular focus on the approach taken by the @EPOorg.
https://t.co/3iqgHpJEQp